Funding

Infinimmune

United States · Biotech · AI

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

Visit infinimmune.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$75MCivilization Ventures — Role not disclosedEverbright Biofund — Role not disclosedForge Life Science Partners — Role not disclosedGodfrey Capital — Role not disclosedGoldcrest Capital — Role not disclosedMerck Global Health Innovation Fund — Role not disclosedPear VC — Role not disclosedPlayground Global — Role not disclosedRA Capital Management — Role not disclosedRegeneron Ventures — Role not disclosedWild Tree Ventures — Role not disclosed

Investors

Civilization VenturesSeries AEverbright BiofundSeries AForge Life Science PartnersSeries AGodfrey CapitalSeries AGoldcrest CapitalSeries AMerck Global Health Innovation FundSeries APear VCSeries APlayground GlobalSeries ARA Capital ManagementSeries ARegeneron VenturesSeries AWild Tree VenturesSeries A

Coverage

Aug 11, 2026Infinimmune · Series A

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesinfinimmune.com ↗